2021 Coagulation Factor Assay Testing Market: US, Europe, Japan--Competitive Landscape, Country Forecasts, Innovative Technologies and Instrumentation

This unique report from LeadingMarketResearch.com provides information and analysis not available from any other published source.

The growing cost-containment pressures in major industrialized nations and continued technological advances will radically change coagulation testing practice during the next five years. New specific and sensitive markers of hemostasis will be increasingly used on automated instrumentation. Coagulation testing in general, and Factor Assays testing specifically, will become more standardized, offering opportunities for quality control products and services.

The report is available by section, and can be customized to specific information needs and budget.

Moreover, the continuing contraction of the hospital system and technological advances will facilitate decentralization of the Factor Assays testing closer to the patient, creating additional opportunities and challenges for suppliers.

This report presents a detailed analysis of the Factor Assays testing market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan, including clinical significance and current laboratory practice, as well as 5-year test volume forecasts by country and market segment.

The report examines market applications of chromogenic substrates, monoclonal antibodies, immunoassays, IT, DNA probes, biochips/microarrays, and other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies alternative market penetration strategies and entry barriers/risks.

Contains 295 pages and 85 tables

I. Introduction
II. Worldwide Market and Technology Overview
A. Introduction
B. Factor Assays: Clinical Significance
and Current Laboratory Procedures
1. Introduction
2. Factor II
3. Factor V/Factor V Leiden
4. Factor VII
5. Factor VIII
6. Factor IX
7. Factor IXa
8. Factor X (Stuart Factor)
9. Factor Xa
10. Factor XI
11. Factor XII
12. Factor XIII
C. Instrumentation: Review of latest analyzers from Bio/Data, Cardiovascular
Diagnostics, Diagnostica Stago, Helena Laboratories, Instrumentation Laboratory,
NexusDx, Roche Diagnostics, Siemens Healthineers, Sysmex, Teco Diagnostics.
D. Major in Vitro Diagnostic Technologies and Their
Potential Applications
1. Chromogenic Substrates
2. Monoclonal and Polyclonal Antibodies
3. Immunoassays
a. Applications
b. Technological Principle
c. Enzyme Immunoassays (EIA)
- Overview
- ELISA
- EMIT
- Dot Immunobinding Assays
- Capillary Immunoassays
- Enzyme Amplification
- Electrochemical Immunoassay
d. Fluorescent Immunoassays
- Fluorescence Polarization
- Time-Resolved Pulse Fluorescence
- Fluorescence Lifetime
e. Latex Agglutination
f. Immunoprecipitation
4. Microcomputers
5. Automation
6. Robotics
7. DNA Probes
a. Overview
b. Amplification Methods
- PCR
- Ligase Chain Reaction
- Branched DNA
- Q-Beta Replicase
- NASBA
- SDA
- 3 SR
- HPA
- Two-Tiered System
- LAT
8. Artificial Intelligence
9. Dry Chemistry
10. Biosensors
III. France: Test Volume Forecasts by Market Segment
IV. Germany: Test Volume Forecasts by Market Segment
V. Italy: Test Volume Forecasts by Market Segment
VI. Japan: Test Volume Forecasts by Market Segment
VII. Spain: Test Volume Forecasts by Market Segment
VIII. UK: Test Volume Forecasts by Market Segment
IX. USA: Test Volume Forecasts by Market Segment
X. Design Criteria For Decentralized Testing Products
XI. Alternative Market Penetration
Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
1. Marketing Approaches
2. Product
Complexity
3. Customer
Preference
4. Established
Suppliers
5. Emerging
Suppliers
6. Major Types Of Distributors
7. Market
Segmentation
XII. Potential Market Entry Barriers and
Risks
A. Market
Maturity B. Cost
Containment C.
Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
CompetitiveAssessments
Abbott
Accriva
Axis-Shield
Beckman Coulter/Danaher
Becton Dickinson
Bio/Data
Chrono-Log
Corgenix
Diagnostica Stago/Trinity Biotech
Grifols
Helena Laboratories
HYPHEN BioMed
Instrumentation Laboratory/Werfen
Roche
Sekisui Diagnostics
Siemens Healthineers
Sienco
Sysmex
Thermo Fisher

List Of Tables

Major Companies Developing or Marketing Factor Assay Tests
France
Factor II Test Volume Forecasts by Market Segment
France
Factor V Test Volume Forecasts by Market Segment
France
Factor V Leiden Test Volume Forecasts by Market Segment
France
Factor VII Test Volume Forecasts by Market Segment
France
Factor VIII Test Volume Forecasts by Market Segment
France
Factor IX Test Volume Forecasts by Market Segment
France
Factor IXa Test Volume Forecasts by Market Segment
France
Factor X (Stuart Factor) Test Volume Forecasts by Market
Segment
France
Factor Xa Test Volume Forecasts by Market Segment
France
Factor XI Test Volume Forecasts by Market Segment
France
List of Tables (continued)
Factor XII Test Volume Forecasts by Market Segment
France
Factor XIII Test Volume Forecasts by Market Segment
Germany
Factor II Test Volume Forecasts by Market Segment
Germany
Factor V Test Volume Forecasts by Market Segment
Germany
Factor V Leiden Test Volume Forecasts by Market Segment
Germany
Factor VII Test Volume Forecasts by Market Segment
Germany
Factor VIII Test Volume Forecasts by Market Segment
Germany
Factor IX Test Volume Forecasts by Market Segment
Germany
Factor IXa Test Volume Forecasts by Market Segment
Germany
Factor X (Stuart Factor) Test Volume Forecasts by Market
Segment
Germany
Factor Xa Test Volume Forecasts by Market Segment
Germany
Factor XI Test Volume Forecasts by Market Segment
Germany
Factor XII Test Volume Forecasts by Market Segment
List of Tables (continued)
Germany
Factor XIII Test Volume Forecasts by Market Segment
Italy
Factor II Test Volume Forecasts by Market Segment
Italy
Factor V Test Volume Forecasts by Market Segment
Italy
Factor V Leiden Test Volume Forecasts by Market Segment
Italy
Factor VII Test Volume Forecasts by Market Segment
Italy
Factor VIII Test Volume Forecasts by Market Segment
Italy
Factor IX Test Volume Forecasts by Market Segment
Italy
Factor IXa Test Volume Forecasts by Market Segment
Italy
Factor X (Stuart Factor) Test Volume Forecasts by Market
Segment
Italy
Factor Xa Test Volume Forecasts by Market Segment
Italy
Factor XI Test Volume Forecasts by Market Segment
Italy
Factor XII Test Volume Forecasts by Market Segment
Italy
Factor XIII Test Volume Forecasts by Market Segment
List of Tables (continued)
Japan
Factor II Test Volume Forecasts by Market Segment
Japan
Factor V Test Volume Forecasts by Market Segment
Japan
Factor V Leiden Test Volume Forecasts by Market Segment
Japan
Factor VII Test Volume Forecasts by Market Segment
Japan
Factor VIII Test Volume Forecasts by Market Segment
Japan
Factor IX Test Volume Forecasts by Market Segment
Japan
Factor IXa Test Volume Forecasts by Market Segment
Japan
Factor X (Stuart Factor) Test Volume Forecasts by Market
Segment
Japan
Factor Xa Test Volume Forecasts by Market Segment
Japan
Factor XI Test Volume Forecasts by Market Segment
Japan
Factor XII Test Volume Forecasts by Market Segment
Japan
Factor XIII Test Volume Forecasts by Market Segment
Spain
Factor II Test Volume Forecasts by Market Segment
List of Tables (continued)
Spain
Factor V Test Volume Forecasts by Market Segment
Spain
Factor V Leiden Test Volume Forecasts by Market Segment
Spain
Factor VII Test Volume Forecasts by Market Segment
Spain
Factor VIII Test Volume Forecasts by Market Segment
Spain
Factor IX Test Volume Forecasts by Market Segment
Spain
Factor IXa Test Volume Forecasts by Market Segment
Spain
Factor X (Stuart Factor) Test Volume Forecasts by Market
Segment
Spain
Factor Xa Test Volume Forecasts by Market Segment
Spain
Factor XI Test Volume Forecasts by Market Segment
Spain
Factor XII Test Volume Forecasts by Market Segment
Spain
Factor XIII Test Volume Forecasts by Market Segment
U.K.
Factor II Test Volume Forecasts by Market Segment
U.K.
Factor V Test Volume Forecasts by Market Segment
List of Tables (continued)
U.K.
Factor V Leiden Test Volume Forecasts by Market Segment
U.K.
Factor VII Test Volume Forecasts by Market Segment
U.K.
Factor VIII Test Volume Forecasts by Market Segment
U.K.
Factor IX Test Volume Forecasts by Market Segment
U.K.
Factor IXa Test Volume Forecasts by Market Segment
U.K.
Factor X (Stuart Factor) Test Volume Forecasts by Market
Segment
U.K.
Factor Xa Test Volume Forecasts by Market Segment
U.K.
Factor XI Test Volume Forecasts by Market Segment
U.K.
Factor XII Test Volume Forecasts by Market Segment
U.K.
Factor XIII Test Volume Forecasts by Market Segment
U.S.A.
Factor II Test Volume Forecasts by Market Segment
U.S.A.
Factor V Test Volume Forecasts by Market Segment
U.S.A.
Factor V Leiden Test Volume Forecasts by Market Segment
List of Tables (continued)
U.S.A.
Factor VII Test Volume Forecasts by Market Segment
U.S.A.
Factor VIII Test Volume Forecasts by Market Segment
U.S.A.
Factor IX Test Volume Forecasts by Market Segment
U.S.A.
Factor IXa Test Volume Forecasts by Market Segment
U.S.A.
Factor X (Stuart Factor) Test Volume Forecasts by Market
Segment
U.S.A.
Factor Xa Test Volume Forecasts by Market Segment
U.S.A.
Factor XI Test Volume Forecasts by Market Segment
U.S.A.
Factor XII Test Volume Forecasts by Market Segment
U.S.A.
Factor XIII Test Volume Forecasts by Market Segment

2021 US Transfusion Diagnostics Market Asseessment: Supplier Shares and Sales Segment Forecasts

This report provides an overview of the US blood banking market, including sales and market shares of leading suppliers of blood typing, grouping and infectious disease screening/NAT tests, as well

USD 1450 View Report

2021 UK Transfusion Diagnostics Market Asseessment: Supplier Shares and Sales Segment Forecasts

This report provides an overview of the UK blood banking market, including sales and market shares of leading suppliers of blood typing, grouping and infectious disease screening tests, as well

USD 1450 View Report

Coagulation Factor XI - Pipeline Review, H2 2020

Coagulation Factor XI - Pipeline Review, H2 2020According to the recently published report Coagulation Factor XI - Pipeline Review, H2 2020; Coagulation Factor XI (Plasma Thromboplastin Antecedent or F11 or

USD 3500 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available